Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.02)
# 1,434
Out of 5,005 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $145.19 | +20.53% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $72.23 | -16.93% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $20.53 | +240.96% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $114.86 | +0.12% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $88.94 | -10.05% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $1.95 | +3,746.15% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $145.19
Upside: +20.53%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $72.23
Upside: -16.93%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $20.53
Upside: +240.96%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $114.86
Upside: +0.12%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $88.94
Upside: -10.05%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $1.95
Upside: +3,746.15%